Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models

Rotenone and 6-hydroxydopamine are two drugs commonly used to generate Parkinson’s disease animal models. They not only achieve degenerative changes of dopaminergic neurons in the substantia nigra, but also satisfy the requirements for iron deposition. However, few studies have compared the characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lan-Xiang, Du, Dan, Wang, Zhan-Qiu, Fang, Yuan, Zheng, Tao, Dong, Yan-Chao, Shi, Qing-Lei, Zhao, Min, Xiao, Fang, Du, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065241/
https://www.ncbi.nlm.nih.gov/pubmed/30028338
http://dx.doi.org/10.4103/1673-5374.235076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065241/
https://www.ncbi.nlm.nih.gov/pubmed/30028338
http://dx.doi.org/10.4103/1673-5374.235076

Ejemplares similares